• 1
    Halsted WS. I. A Clinical and histological study of certain adenocarcinomata of the breast: and a brief consideration of the supraclavicular operation and of the results of operations for cancer of the breast from 1889 to 1898 at the Johns Hopkins Hospital. Ann Surg 1898; 28: 557576.
  • 2
    Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002; 347: 12271232.
  • 3
    Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002; 347: 12331241.
  • 4
    Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 366: 20872106.
  • 5
    Ballard-Barbash R, Potosky AL, Harlan LC, Nayfield SG, Kessler LG. Factors associated with surgical and radiation therapy for early stage breast cancer in older women. J Natl Cancer Inst 1996; 88: 716726.
  • 6
    Katz SJ, Lantz PM, Janz NK, Fagerlin A, Schwartz K, Liu L et al. Patient involvement in surgery treatment decisions for breast cancer. J Clin Oncol 2005; 23: 55265533.
  • 7
    Locker GY, Sainsbury JR, Cuzick J. Breast surgery in the ‘Arimidex, Tamoxifen Alone or in Combination’ (ATAC) trial: American women are more likely than women from the United Kingdom to undergo mastectomy. Cancer 2004; 101: 735740.
  • 8
    Nattinger AB. Variation in the choice of breast-conserving surgery or mastectomy: patient or physician decision making? J Clin Oncol 2005; 23: 54295431.
  • 9
    Winchester DP, Cox JD. Standards for diagnosis and management of invasive breast carcinoma. American College of Radiology. American College of Surgeons. College of American Pathologists. Society of Surgical Oncology. CA Cancer J Clin 1998; 48: 83107.
  • 10
    Goldhirsch A, Glick JH, Gelber RD, Senn HJ. Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. J Natl Cancer Inst 1998; 90: 16011608.
  • 11
    Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 365: 16871717.
  • 12
    Coombes RC, Kilburn LS, Snowdon CF, Paridaens R, Coleman RE, Jones SE et al. Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial. Lancet 2007; 369: 559570.
  • 13
    Forbes JF, Cuzick J, Buzdar A, Howell A, Tobias JS, Baum M; Arimidex, Tamoxifen, Alone or in Combination (ATAC) Trialists' Group. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial. Lancet Oncol 2008; 9: 4553.
  • 14
    Goss PE, Ingle JN, Pater JL, Martino S, Robert NJ, Muss HB et al. Late extended adjuvant treatment with letrozole improves outcome in women with early-stage breast cancer who complete 5 years of tamoxifen. J Clin Oncol 2008; 26: 19481955.
  • 15
    Koeberle D, Thuerlimann B. Letrozole as upfront endocrine therapy for postmenopausal women with hormone-sensitive breast cancer: BIG 1–98. Breast Cancer Res Treat 2007; 105(Suppl 1): 5566.
  • 16
    Coombes RC, Hall E, Gibson LJ, Paridaens R, Jassem J, Delozier T et al. A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med 2004; 350: 10811092.
  • 17
    Markopoulos C. Aromatase inhibitors in the management of early breast cancer: the TEAM trial. Eur J Surg Oncol 2009; 35: 333.
  • 18
    Athas WF, Adams-Cameron M, Hunt WC, Amir-Fazli A, Key CR. Travel distance to radiation therapy and receipt of radiotherapy following breast-conserving surgery. J Natl Cancer Inst 2000; 92: 269271.
  • 19
    Scalliet PG, Kirkove C. Breast cancer in elderly women: can radiotherapy be omitted? Eur J Cancer 2007; 43: 22642269.
  • 20
    Thürlimann B, Keshaviah A, Coates AS, Mouridsen H, Mauriac L, Forbes JF et al.; Breast International Group (BIG) 1–98 Collaborative Group. A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. N Engl J Med 2005; 353: 27472757.
  • 21
    Jassem J, Coombes RC, Ireland B, Hall E, Snowdon CF, Bliss JM. Approaches to postmastectomy radiotherapy (PMRT) in the intergroup exemestane study (IES). Proc ESTRO 2006; poster 680.